itraconazole has been researched along with Bile Duct Obstruction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, J; Ito, K; Santa, T; Suzuki, H; Takada, T; Tsuji, S; Yamaji, H; Yamamoto, T; Yatomi, Y; Yokota, H; Yoshida, H; Yoshikado, T | 1 |
Bryceson, AD; Flanagan, KL | 1 |
2 other study(ies) available for itraconazole and Bile Duct Obstruction
Article | Year |
---|---|
Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3/ABCB4.
Topics: Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; Bile Canaliculi; Blotting, Western; Cholestasis; Itraconazole; LLC-PK1 Cells; Male; Rats; Rats, Sprague-Dawley | 2011 |
Disseminated infection due to Bipolaris australiensis in a young immunocompetent man: case report and review.
Topics: Adult; Amphotericin B; Antifungal Agents; Cholestasis; Drug Therapy, Combination; Humans; Itraconazole; Lung Diseases, Fungal; Lymphatic Diseases; Male; Mediastinal Diseases; Mitosporic Fungi; Mycoses; Pericardial Effusion; Ureteral Obstruction | 1997 |